Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.7
4.8
Journals
Pharmaceuticals
Special Issues
Exploring Natural Products as Modulators of Oxidative Stress in Health...
share announcement

Exploring Natural Products as Modulators of Oxidative Stress in Health and Disease

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".

Deadline for manuscript submissions: closed (25 October 2024) | Viewed by 5658

Special Issue Editors

Dr. Antonella Di Sotto

E-Mail Website
Guest Editor
Department of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, Rome, Italy
Interests: natural substances; herbal extracts; waste; plant phytocomplexes; polyphenols; terpenoids; cancer chemoprevention; chemoresistance; STAT3; Pgp; Nrf2; DNA-damage; metabolic reprogramming; autophagy; genoprotection; hypoglycemic activity; antiglycative properties; antioxidant defenses; antiviral herbal extracts; inflammation; immunomodulation
Special Issues, Collections and Topics in MDPI journals
Dr. Silvia Di Giacomo

E-Mail Website
Guest Editor
Unit of Human Nutrition and Health, Department of Food Safety, Nutrition and Veterinary Public Health, Italian National Institute of Health, 00161 Rome, Italy
Interests: food supplements; nutrition; nutritional epidemiology; food safety; botanical safety; nutrient intake; obesity; lifestyle; sport nutrition; food consumption; nutritional status; vitamins; minerals; phytochemicals
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, natural products have become increasingly popular due to the wide range of biological activities ascribed to them. In particular, their ability to modulate oxidative stress, which plays a pivotal role in the development and progression of several pathologic conditions (e.g., neurodegeneration, cardiovascular diseases, metabolic ailments, diabetes mellitus, aging, and cancer), has been proposed as a potential strategy via which to promote human health.

Since the complete avoidance of the factors that trigger oxidative stress is not feasible, enhancing the cellular antioxidant system by using natural products could represent an alternative technique able to tackle this problem. Epidemiological studies have demonstrated an association between natural antioxidants and human health, suggesting that they are mainly effective in counteracting non-communicable diseases, such as neurodegenerative and cardiovascular diseases, diabetes, and cancer.

However, from the other side, overexposure to natural antioxidants can also lead to adverse effects, especially in highly susceptible people, such as cancer patients. Moreover, other adverse reactions may occur as a consequence of polymorphisms, concomitant pathologies, or pharmacological treatments. In this scenario, it is of the outmost importance to elucidate the role of natural products in oxidative stress modulation, in order to better harness their benefits while avoiding the possible risk of toxicity.

In line with this evidence, the aim of this Special Issue is to collect original articles and review papers focused on unveiling the dual antioxidant or pro-oxidant role of natural products and the possible pharmaceutical applications and safety.

The scope of this Special Issue includes, but is not limited to, the following:

  • discovering novel sources of antioxidants, with a special focus on chemically characterized extracts from medicinal plants, waste materials, and innovative plant production;
  • investigating the role of antioxidant agents in countering various pro-oxidant stressors and their effectiveness in experimental models of inflammatory and oxidative-related diseases;
  • unravelling the mechanism underlying the potential adverse reactions associated with antioxidant agents;
  • exploring the effects on cell signaling pathways and molecular targets;
  • carrying out pharmacokinetic and digestion studies to better understand the absorption and metabolism of antioxidants;
  • clarifying the safety and efficacy of antioxidants in clinical trials.

Special attention will be devoted to papers addressing the role of antioxidants in cancers (e.g., Nrf2 modulators) and in liver damage. Papers presenting pharmaceutical formulations that are able to improve the bioavailability and delivery of antioxidants to targets are also welcome.

Dr. Antonella Di Sotto
Dr. Silvia Di Giacomo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • plant-based herbal extracts
  • waste
  • natural substances
  • medicinal plants
  • food supplements
  • liver
  • cancer
  • noncommunicable diseases
  • chemoprevention
  • molecular mechanisms
  • adverse reactions
  • safety

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

22 pages, 7927 KiB  
Article
Chemical Investigation and Regulation of Adipogenic Differentiation of Cultivated Moringa oleifera
by Duc Dat Le, Eunbin Kim, Thinhulinh Dang, Jiseok Lee, Choon Ho Shin, Jin Woo Park, Seul-gi Lee, Jong Bae Seo and Mina Lee
Pharmaceuticals 2024, 17(10), 1310; https://doi.org/10.3390/ph17101310 - 1 Oct 2024
Cited by 1 | Viewed by 1563
Abstract
Background/Objectives: Moringa oleifera is a matrix plant with the high potential to cure several diseases with its medicinal and ethnopharmacological value and nutraceutical properties. In this study, we investigated the chemical and biological properties of this plant cultivated in our local region. [...] Read more.
Background/Objectives: Moringa oleifera is a matrix plant with the high potential to cure several diseases with its medicinal and ethnopharmacological value and nutraceutical properties. In this study, we investigated the chemical and biological properties of this plant cultivated in our local region. Methods: Leaves, roots, seeds, stem bark, and twigs of oleifera were extracted and evaluated bioactivities targeting intracellular lipid accumulation and adipocyte differentiation in 3T3-L1 preadipocytes, and UHPLC-ESI-Orbitrap-MS/MS-Based molecular networking guided isolation and dereplication of metabolites from these extracts. Results: Five extracts of different organs of M. oleifera significantly stimulated intracellular lipid accumulation and adipocyte differentiation in 3T3-L1 preadipocytes in a concentration-dependent manner. These extracts markedly increased the expression of genes related to adipogenesis and lipogenesis. Notably, these extracts promoted peroxisome proliferator-activated receptor γ (PPARγ) activity and the expression of its target genes, including phosphoenolpyruvate carboxykinase, fatty acid-binding protein 4, and perilipin-2. These adipogenic and lipogenic effects of Moringa extracts through the regulation of PPARγ activity suggests their potential efficacy in preventing or treating type 2 diabetes. Furthermore, chemical investigation revealed high contents of phytonutrients as rich sources of secondary metabolites including glycosides, flavones, fatty acids, phenolics, and other compounds. In addition, in silico studies on major components of these extracts revealed the bioavailability of major components through their binding affinity to respective proteins targeting adipocyte differentiation. Full article
(This article belongs to the Special Issue Exploring Natural Products as Modulators of Oxidative Stress in Health and Disease)
►▼ Show Figures

Figure 1

18 pages, 9761 KiB  
Article
Phenylethanol Glycoside from Cistanche tubulosa Attenuates BSA-Induced Liver Fibrosis in Rats by Modulating the Gut Microbiota–Liver Axis
by Xinxin Qi, Hongguang Sun, Jincun Liu, Meili Cong, Xinxuan Zhang, Yuxin Yan, Zhaolin Xia, Tao Liu and Jun Zhao
Pharmaceuticals 2024, 17(9), 1149; https://doi.org/10.3390/ph17091149 - 30 Aug 2024
Cited by 1 | Viewed by 1609
Abstract
This study aimed to investigate the effect of phenylethanol glycoside from Cistanche tubulosa (CPhGs) on the prevention of bovine serum albumin (BSA)-induced hepatic fibrosis in rats. Investigation of the mechanisms of the anti-hepatic fibrosis effect was focused on CPhGs’ influence on the “gut–liver” [...] Read more.
This study aimed to investigate the effect of phenylethanol glycoside from Cistanche tubulosa (CPhGs) on the prevention of bovine serum albumin (BSA)-induced hepatic fibrosis in rats. Investigation of the mechanisms of the anti-hepatic fibrosis effect was focused on CPhGs’ influence on the “gut–liver” regulation, including the gut microbiota, intestinal barrier, systemic lipopolysaccharide (LPS) concentration, and LPS-related signaling pathway. The results show that CPhGs restored the diversity of gut microbiota, increased the relative abundance of Bacteroidetes, and decreased the relative abundance of Firmicutes and Proteobacteria in the fibrotic rats. In addition, CPhGs promoted the enrichment of probiotics such as Blautia, Oscillospira, Ruminococcus, Odoribacter, Bacteroides, and Parabacteroides in intestines of these rats. Furthermore, CPhGs reduced histopathological injury in the intestine and restored the tight junctions of the intestine by increasing the expression of ZO-1, occludin, and E-cadherin. CPhGs efficiently reduced serum LPS and liver lipopolysaccharide-binding protein (LBP) levels and inhibited the LPS-TLR4/MyD88/NF-κB pathway, which is related to protein expression in the liver. Correlation analysis confirmed that these beneficial bacteria were negatively associated with pathological damage, while LPS and harmful bacteria were positively associated with liver injury. Our fecal microbiota transplantation (FMT) experiment confirmed that gut microbiota is an important part of disease progression and that CPhGs is useful for the prevention and treatment of hepatic fibrosis. Our data demonstrate that the anti-hepatic fibrosis mechanism of CPhGs was mediated by regulation of the “gut–liver” axis. These results can stimulate consideration for its use in clinical practices. Full article
(This article belongs to the Special Issue Exploring Natural Products as Modulators of Oxidative Stress in Health and Disease)
►▼ Show Figures

Figure 1

15 pages, 4959 KiB  
Article
Protective Effects of Lycium ruthenicum Murray against Acute Alcoholic Liver Disease in Mice via the Nrf2/HO-1/NF-κB Signaling Pathway
by Niantong Xia, Zimian Ding, Mingran Dong, Shuyang Li, Jia Liu, Hongwei Xue, Zhigang Wang, Juan Lu and Xi Chen
Pharmaceuticals 2024, 17(4), 497; https://doi.org/10.3390/ph17040497 - 13 Apr 2024
Cited by 8 | Viewed by 1730
Abstract
Acute alcoholic liver disease (ALD) resulting from short-term heavy alcohol consumption has become a global health concern. Moreover, anthocyanins have attracted much attention for their ability to prevent oxidation and inflammation. The present work evaluates the protective effects of Lycium ruthenicum Murray (LRM) [...] Read more.
Acute alcoholic liver disease (ALD) resulting from short-term heavy alcohol consumption has become a global health concern. Moreover, anthocyanins have attracted much attention for their ability to prevent oxidation and inflammation. The present work evaluates the protective effects of Lycium ruthenicum Murray (LRM) against ALD and explores the possible underlying mechanism involved. The total anthocyanin content in LRM was 43.64 ± 9.28 Pt g/100 g dry weight. Mice were orally administered 50, 125, or 375 mg LRM/kg body weight (BW) for 21 days. On days 18–21, mice were orally administered 15 mL of ethanol/kg BW. Markers of liver damage, oxidative stress, and inflammation were examined. Furthermore, the modulatory effect of LRM on Nrf2/HO-1/NF-κB pathway molecules was evaluated through quantitative reverse transcription polymerase chain reaction (RT‒qPCR) and immunohistochemistry analyses. The difference between the groups indicated that LRM improved liver histopathology and the liver index, decreased aspartate transaminase, alanine transaminase, malondialdehyde, reactive oxygen species, IL-6, TNF-α, and IL-1β expression, but elevated superoxide dismutase, catalase, and glutathione-s-transferase levels. Moreover, LRM upregulated Nrf2 and Ho-1 but downregulated Nf-κb and Tnf-α genes at the transcript level. In summary, LRM alleviated ethanol-induced ALD in mice by reducing oxidative damage and associated inflammatory responses. LRM protects against ALD by reducing damage factors and enhancing defense factors, especially via the Nrf2/HO-1/NF-κB pathway. Thus, LRM has application potential in ALD prophylaxis and treatment. Full article
(This article belongs to the Special Issue Exploring Natural Products as Modulators of Oxidative Stress in Health and Disease)
►▼ Show Figures

Graphical abstract

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop